Loading...
Market
What will be Kezar's stock price range by end of Q1 2025?
3
Resolution / Starting Odds
Below $1.00 • 25%
$1.00 - $1.50 • 25%
$1.51 - $2.00 • 25%
Above $2.00 • 25%
Stock market data from NASDAQ or other financial platforms
Story
Kezar Life Sciences Receives $1.10/Share Proposal from Concentra Biosciences, Shares Up 4.7%
Oct 10, 2024, 12:34 PM
Kezar Life Sciences (KZR) has received an unsolicited, non-binding acquisition proposal from Concentra Biosciences. The offer includes a cash payment of $1.10 per share and a contingent value right (CVR). This proposal follows Tang Capital Management's disclosure of a 9.9% stake in Kezar as of October 1, 2024, indicating strong investment confidence in the company’s pipeline of therapies for immune-mediated and oncologic disorders. Tang Capital is the controlling stockholder of Concentra Biosciences. Kezar's shares have risen by 4.7% in premarket trading following the news.
View original story
Similar markets
Increase by more than 20% • 25%
Increase by up to 20% • 25%
Decrease by up to 20% • 25%
Decrease by more than 20% • 25%
Above $30 • 25%
$20-$30 • 25%
$10-$20 • 25%
Below $10 • 25%
Below $40 • 25%
$40 to $45 • 25%
$45 to $50 • 25%
Above $50 • 25%
Below $40 • 25%
$40 to $45 • 25%
$45 to $50 • 25%
Above $50 • 25%
Above $300 • 25%
$250 to $300 • 25%
$200 to $250 • 25%
Below $200 • 25%
Below $250 • 25%
$301 to $350 • 25%
Above $350 • 25%
Below $300 • 25%
$300 to $350 • 25%
$351 to $400 • 25%
Above $400 • 25%
Below $370 • 25%
$370 to $414.50 • 25%
$414.51 to $500 • 25%
$401 to $450 • 25%
Below $350 • 25%
$350 to $400 • 25%
$400 to $450 • 25%
Above $450 • 25%
$450 to $500 • 25%
Below $400 • 25%
$400 - $450 • 25%
$451 - $500 • 25%
Above $500 • 25%
Below €25 • 25%
€25 to €30 • 25%
€30 to €35 • 25%
Above €35 • 25%
Less than $10 • 25%
$10 to $15 • 25%
$15 to $20 • 25%
More than $20 • 25%
Above $10 • 25%
$5 to $10 • 25%
$1 to $5 • 25%
Below $1 • 25%
Below $90 • 25%
$90 - $110 • 25%
$110 - $130 • 25%
Above $130 • 25%
Below $300 • 25%
$300 to $350 • 25%
$350 to $400 • 25%
Above $400 • 25%
Below $10 • 25%
$10 to $15 • 25%
$15 to $20 • 25%
Above $20 • 25%
Less than $1B • 25%
$1B to $2B • 25%
$2B to $3B • 25%
More than $3B • 25%